Drawing for EXELINT INTERNATIONAL

USPTO serial 85312218

EXELINT INTERNATIONAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CLARKE, NANCY
Law office
TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EXELINT INTERNATIONAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Afsoon Hamid

AFSOON HAMID EXELINT INTERNATIONAL CO.5840 W CENTINELA AVELOS ANGELES, CA 90045-1504UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anesthetics for surgical and non-surgical use; absorbent adhesive bandageACTIVEJun 23, 2003
010medical syringes; medical syringes to inject insulin; injection needles; insulin needles; lancets; medical safety syringes; tuberculin syringes; hypodermic needles; aluminum hub needles; radiopaque aluminum hub needles; multi-sample needles; luer adapters, namely, a locking device used to secure a needle or a tube; luer holder, namely, the structure used in holding the luer adapter or multi-drawing needle for the purpose of taking blood; multi-sample luer holders, namely, the structure used in holding the liter adapter or multi-drawing needle, allowing multiple samples to be taken, for the purpose of taking blood; injection plugs, namely, the plug connected to the luer used for injection or drawing liquids; blood collection sets; safety blood collection sets; IV cannulas; IV catheters; spinal needles; dental needles; central venous catheters; scalp vein sets, namely, tube, tube fittings, wing, needle, and luer connector, used to access veins; safety scalp vein sets, namely, tube, tube fittings, wing, needle, and luer connector, that has a safety feature to cover the needle, used to access veins; huber needles, namely, a needle with along beveled angled tip; huber inffision sets, namely, huber needle, wing, tube, and fittings; safety huber infusion sets, namely, huber needle, wing, tube, and fittings, with a safety feature for covering the needle; tracheal tubes; silicon coated latex foley catheters; all silicon foley catheters; nebulizers with mask for respiration therapy; venturi masks designed to deliver specific levels of oxygen concentration; AV fistulas, namely, needle, wing, tube, luer connector, fittings used as a set for infusion and transfusion; latex medical examination gloves; surgical blades; disposable scalpels; IV administration sets; filtered IV administration sets; burrette sets, namely, measured volume fluid administration set; pen needles, namely, needle which is embedded in a hub that attaches to injection pens; medical syringes for injecting allergy medicines; curved tip medical syringes; U-40 medical syringes marked with a 40-unit milliliter scale; polypropylene hub hypodermic needles; drenching medical syringes; bulb type medical syringes; intravenous feeding tubes; blood collection sets; Apparatus for blood analysis; Apparatus for taking blood; Apparatus for taking blood samples; Blood component separation apparatus for medical purposes; Blood drawing apparatus; Blood testing apparatusACTIVEAug 1, 1987

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 15, 2012MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 15, 2012ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 14, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 14, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 14, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 20, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 20, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2011ALIEASSIGNED TO LIE—
Dec 12, 2011MAILPAPER RECEIVED—
Jul 24, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2011DOCKASSIGNED TO EXAMINER—
May 10, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance